TrialPath
Recruiting

Relationship Between Aspirin Metabolism and Markers of Metabolic Dysfunction Among Pregnant Persons at Risk of Pre-eclampsia

NCT06802861 · University of Tennessee Graduate School of Medicine
In plain English

Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.

About this study
This study's primary purpose is to determine the relationship between aspirin metabolism and markers of metabolic dysfunction among patients at risk for preeclampsia.
Eligibility criteria
Inclusion Criteria: * Recommended aspirin for pre-eclampsia prevention by OB/GYN or MFM specialist based on ACOG and USPSTF guidelines (1 high risk factor, 2+ moderate risk factors) * Willingness to adhere to aspirin therapy * Willingness to undergo 2h OGTT for serum and urine collection in addition to survey collection, indirect calorimetry, body composition measures, neonatal measures, etc. * Gestational age at enrollment \<16 weeks * Ability to speak, read, and communicate via English Exclusion Criteria: * Type 2 Diabetes Mellitus * Type 1 Diabetes Mellitus * Current gestational diabetes mellitus * Current/active platelet disorder or bleeding diathesis (thrombocytopenia of any etiology, idiopathic thrombocytopenic purpura/ITP, thrombotic thrombocytopenic purpura/TTP, von Willebrand disease, etc.) * Thrombophilia * Current use of NSAID for other indication (indomethacin, ibuprofen, etc.) * Current use of other immune-modulating agents and biologics (hydroxychloroquine, azathioprine, 6-mercaptopurine, IL-6 inhibitors, etc.) * Current or recent use of steroids * Current use of prophylactic or therapeutic anticoagulation * Medical contraindication to aspirin therapy * Molar pregnancy * Renal disease * Inability or unwillingness to give informed consent * Current psychiatric illness/social situation that would limit compliance with study requirements, as determined by the principal investigators
Study design
Enrollment target: 50 participants
Age groups: adult
Timeline
Starts: 2025-01-01
Estimated completion: 2028-12-31
Last updated: 2025-09-10
Primary outcomes
  • • Hexadecadienoate (z score) (60 minutes after ingestion of 75 grams of glucose during a single study visit between 14-20 weeks gestational age)
  • • Salicylate (z score) (60 minutes after ingestion of 75 grams of glucose during a single study visit between 14-20 weeks gestational age)
Sponsor
University of Tennessee Graduate School of Medicine · other
Contacts & investigators
ContactJill M Maples, PhD · contact · jmaples1@utmck.edu · 865-305-9367
All locations (1)
University of Tennessee Medical CenterRecruiting
Knoxville, Tennessee, United States
Relationship Between Aspirin Metabolism and Markers of Metabolic Dysfunction Among Pregnant Persons at Risk of Pre-eclampsia · TrialPath